Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies
Hepatobiliary Surgery and Nutrition · 2023-08 · 12 (4) · 478-494
DOI: 10.21037/hbsn-21-424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatobiliary Surgery and Nutrition, 2023-08. Verfasst von Xing Chen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery & Liver Transplantation, Laboratory of Liver Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Ho…. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Clinical parameter-based nomograms and staging systems provide limited information for the prediction of survival in intrahepatic cholangiocarcinoma (ICC) patients. In this study, we developed a methylation signature that precisely predicts overall survival (OS) after surgery.
Methods
An epigenome-wide study of DNA methylation based on whole-genome bisulfite sequencing (WGBS) was conducted for two independent cohorts (discovery cohort, n=164; validation cohort, n=170) from three hepatobiliary centers in China. By referring to differentially methylated regions (DMRs), we proposed the concept of prognostically methylated regions (PMRs), which were composed of consecutive prognostically methylated CpGs (PMCs). Using machine learning strategies (Random Forest and the least absolute shrinkage and selector regression), a prognostic methylation score (PMS) was constructed based on 14 PMRs in the discovery cohort and confirmed in the validation cohort.
Results
The C-indices of the PMS for predicting OS in the discovery and validation cohorts were 0.79 and 0.74, respectively. In the whole cohort, the PMS was an independent predictor of OS [hazard ratio (HR) =8.12; 95% confidence interval (CI): 5.48-12.04; P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Liver Surgery & Liver Transplantation, Laboratory of Liver Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biot…
- Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Shanghai, China.
- Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
- Department of Hepatobiliary Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Ce…
- The Fifth Affiliated Hospital, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.
- Department of Research and Development, Jiangsu Gaomei Genomics, Nanjing, China.
Zitieren
APA
Chen, X., Dong, L., Chen, L., Wang, Y., Du, J., Ma, L., Yan, X., Huang, J., Liao, M., Chen, X., Liu, D., Li, J., Zhang, B., Teng, W., Yuan, K., Sun, D., Gao, Q., & Zeng, Y. (2023). Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies. Hepatobiliary Surgery and Nutrition, 12(4), 478-494. https://doi.org/10.21037/hbsn-21-424
Vancouver
Chen X, Dong L, Chen L, Wang Y, Du J, Ma L, et al. Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies. Hepatobiliary Surgery and Nutrition. 2023;12(4):478-494. doi:10.21037/hbsn-21-424
BibTeX
@article{Chen2023,
author = {Chen, Xing and Dong, Liangqing and Chen, Lu and Wang, Yuan and Du, Jinpeng and Ma, Lijie and Yan, Xiaokai and Huang, Jiwei and Liao, Mingheng and Chen, Xiangzheng and Liu, Dongming and Li, Jin and Zhang, Bo and Teng, Wen and Yuan, Kefei and Sun, Deqiang and Gao, Qiang and Zeng, Yong},
title = {Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies},
journal = {Hepatobiliary Surgery and Nutrition},
year = {2023},
volume = {12},
number = {4},
pages = {478--494},
doi = {10.21037/hbsn-21-424}
}
EUVIMED